Definitive Contract 75F40122C00197
Award Date 9/28/22
Potential Completion Date 3/29/25
Potential Value $408K
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Calverton, MD 20705, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $897,471 firm-fixed-price delivery order contract awarded by the Food and Drug Administration (FDA) to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), doing business as Inhalation Toxicology Research Institute. The contract is part of a larger In Vivo Toxicology of Tobacco 2015-2020 indefinite-delivery, indefinite-quantity (IDIQ) contract vehicle. LBERI, a non-profit contract research organization, will provide preclinical research services to support the...
- This definitive, firm fixed-price contract was awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to CFD Research Corporation, a for-profit organization, to develop a multiscale computational framework for assessing the bioequivalence of orally inhaled drugs. The $499,761 contract does not have a set-aside designation. The original solicitation was a Broad Agency Announcement (BAA) seeking research and development to advance FDA's mission of protecting...
- This is a firm fixed price delivery order awarded by the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services, to Labstat International Inc., a for-profit limited liability company based in Canada. The $619,328.55 contract is for the chemical and physical characterization of pod and disposable e-cigarette aerosol. This order is part of a larger $45 million single-award Indefinite Delivery Indefinite Quantity (IDIQ) contract held by Labstat...
- This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian agency within the Department of Health and Human Services (HHS), to TSE Systems, Inc., a for-profit manufacturer of advanced biomedical research equipment and scientific instrumentation. The $139,585.14 contract is for the delivery of an additional sampling system to fit on existing inhalation exposure units, along with a post-warranty service agreement option. The award does not have a...
- This is a delivery order contract awarded by the Food and Drug Administration (FDA) to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a non-profit research organization, to develop a standard guideline protocol for rodent tobacco smoke inhalation studies. The contract has a ceiling value of $1,373,599.00 and is a firm fixed-price task order issued under the "In Vivo Toxicology of Tobacco 2015-2020" indefinite-delivery, indefinite-quantity (IDIQ) contract. The...
- This is a definitive cost-plus-fixed-fee contract awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to Physical Sciences Inc., a for-profit research and development company. The contract was awarded under FDA Broad Agency Announcement BAA-18-00123, titled "Single Vial Mass Flow Rate Sensor Assessment of Freeze Drying Heterogeneity", with Proposal Number PMQWP#195. The contract has a potential value of $959,248.00 and a completion date of December...
- This is a $1,127,883.00 firm fixed-price delivery order contract awarded by the Department of Health and Human Services Food and Drug Administration to Battelle Memorial Institute, a nonprofit research organization, to study the human dose-response effects of methyl salicylate in smokeless tobacco products. The contract has a completion date of March 29, 2024 and was awarded on September 24, 2019 without the use of a set-aside. Battelle has subcontracted with three organizations to support...
- The U.S. Food and Drug Administration's Office of Acquisition and Grants Services awarded a $66,965 firm fixed-price purchase order to TSI Incorporated for the procurement of an automated realistic breathing simulator under solicitation FDA-RFQ-CDER-2022-111. The award, issued on July 21, 2022, with an ultimate completion date of July 29, 2023, involves no set-aside designation. TSI Incorporated, a Minnesota-based manufacturer of precision measurement instruments specializing in aerosol...
- The Food and Drug Administration (FDA) awarded a firm fixed-price purchase order to TSE Systems, Inc. on February 16, 2023, for preventative and corrective maintenance and repair services on six TSE Inhalation Exposure Units located in Beltsville, Maryland. The contract, valued at $544,988 and scheduled for completion by March 31, 2027, encompasses planned preventative maintenance visits, onsite corrective maintenance within eight hours of request, unlimited phone and email support, and services...
- This is a $1,215,324.40 Firm Fixed Price Delivery Order issued by the Food and Drug Administration (FDA) to Labstat International Inc., a leading analytical testing laboratory in Kitchener, Ontario. The contract is for Tobacco Lab Analysis Services and is part of a larger $45 million Indefinite Delivery Indefinite Quantity (IDIQ) contract awarded to Labstat to provide laboratory services in support of the FDA's regulatory oversight of tobacco products. The contract covers a range of technical...